Clinical Trial

Normal Hemostasis Values in Premature Infants

Study acronym: PRHEMO
Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to retrospectively determine, in a large cohort of apparently healthy children born before 37 weeks of gestation, the expected values of certain hemostasis parameters from birth to 18 months (when they start walking), and to determine whether or not they differ from those of full-term infants.
Trial Details
NCT Number NCT07349251
Lead Sponsor University Hospital, Strasbourg, France
Conditions Premature Infant, Hemostasis
Enrollment 1,000 participants
Start Date 2025-11-24
Primary Completion 2031-11 (estimated)
Study Completion 2031-11-24 (estimated)
Updated on ClinicalTrials.gov 2026-01-16